Login
← Go Back
Concord Biotech
CONCORDBIO · Pharma > Pharmaceuticals & Drugs Listing date: Aug. 18, 2023
Stock Price vs Company Growth
1d
0.5%
1w
8.6%
1m
9.5%
3m
22.1%
6m
12.4%
1y
14.4%
all
45.2%
Created with Highcharts 8.2.2SalesProfitPriceDividendQtr SalesOperating CashflowJun22Dec22Jun23Dec23Jun24Latest
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 1,742 0.5%
1,401
2,452
Company Overview
Sales
1,089 Cr
Growth: 16.0%
Profit after Tax
326 Cr
Growth: -0.5%
Mid Cap
18,222 Cr
P/E: 55.8x
Industry P/E: 30.4x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals
Sales (Cr) ₹ 1,089
Growth 16.0%
EBITDA 41.3%
P/S 16.7x
Dividend 0.6%
P/E 55.8x
Book Value ₹ 168
PEG Ratio 3.5x
ROE 19.9%
P/B 10.3x
Shareholding Pattern
Institutions
Created with Highcharts 8.2.2Jun24Sep24
Promoters
Created with Highcharts 8.2.2Jun24Sep24
Others
Created with Highcharts 8.2.2Jun24Sep24
Increase    Decrease    No change
Company Profile Detailed
The company is an India-based biopharma company and one of the leading global developers and manufacturers of select fermentation-based APIs across Immunosuppressants and oncology.
Belongs to (17 Indices) view more
Followers (1)
varsha96